Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

A 5-year-old girl's scalp scarring and hair loss from lupus improved with specific medications.

An 18-year-old girl with pemphigus vulgaris needed strong medication and careful treatment due to ineffective initial therapies and side effects.

Ectoin helps prevent cortisone-induced skin problems and supports skin health.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

The ovary mainly causes high testosterone in PCO, while the adrenal gland is the main source in IH.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Intralesional corticosteroids and 5-alpha-reductase inhibitors are the best treatments for frontal fibrosing alopecia.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

Tofacitinib works well for treating alopecia areata, especially when combined with corticosteroids, but is less effective if the disease has lasted over 2 years.

Intralesional triamcinolone acetonide via Dermojet is highly effective for treating alopecia areata.

The patient's scalp lesions stabilized with a combination of treatments after initial therapies failed.

Neuroactive steroids affect cocaine's rewarding effects through the ς₁ receptor.

The combination therapy improved severe alopecia areata in a patient after 14 days.

Hair cortisol levels can effectively indicate long-term hormone activity.

Glucocorticoids reduce fat production in liver cells, while androgens increase it in females; manipulating certain enzymes can influence these effects.

Treatment with corticosteroids and zinc injections can help hair regrowth and restore pigmentation in alopecia totalis.

Allergen desensitization reduces hair loss severity in dust-mite allergic alopecia areata patients.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

A rare skin reaction occurred when a man took paracetamol, causing a new rash in an area already affected by hair loss.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Intralesional triamcinolone acetonide effectively treats alopecia areata, as shown by significant improvements in hair regrowth and dermoscopic indicators.

Topical calcineurin inhibitors, especially 0.1% tacrolimus ointment, are effective and well-tolerated for treating cutaneous lupus erythematosus but require more research for standard treatment guidelines.

Both concentrations of triamcinolone acetonide are equally effective and safe for treating patchy alopecia areata.

Long-term anabolic steroid use can lead to heart and metabolic health issues.

Hair cortisol measurement is a promising, non-invasive tool for monitoring cortisol exposure over time.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Isotretinoin with tacrolimus may be more effective short-term for treating frontal fibrosing alopecia than finasteride with tacrolimus.

Methotrexate plus prednisolone had the fewest serious side effects.